Thomas [Last Name Unknown]'s questions to Ardelyx Inc (ARDX) leadership • Q3 2024
Question
An analyst on for Ed Arce asked for the latest gross-to-net (GTN) for IBSRELA, the potential for future improvement, and whether XPHOZAH sales guidance for next year could be expected at the same time as IBSRELA's.
Answer
Chief Financial and Operations Officer, Justin Renz, stated that IBSRELA's Q3 GTN was 30.0%, in line with the 30% +/- 5% range, and noted GTN is typically higher in Q1. President and CEO, Mike Raab, commented that it would be premature to expect XPHOZAH guidance early next year due to the moving parts surrounding its reimbursement.